Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-25-005019
Filing Date
2025-04-18
Accepted
2025-04-18 16:28:40
Documents
22
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A ocul-20250611xpre14a.htm   iXBRL PRE 14A 1646890
2 GRAPHIC ocul-20250611xpre14a_a003.jpg GRAPHIC 6350
3 GRAPHIC ocul-20250611xpre14a_a011.jpg GRAPHIC 50100
4 GRAPHIC ocul-20250611xpre14a_a012.jpg GRAPHIC 51816
5 GRAPHIC ocul-20250611xpre14a_bg001.jpg GRAPHIC 141309
6 GRAPHIC ocul-20250611xpre14a_bg002.jpg GRAPHIC 97570
  Complete submission text file 0001558370-25-005019.txt   3836576

Data Files

Seq Description Document Type Size
7 EX-101.SCH ocul-20250611.xsd EX-101.SCH 5446
8 EX-101.DEF ocul-20250611_def.xml EX-101.DEF 3923
9 EX-101.LAB ocul-20250611_lab.xml EX-101.LAB 17618
10 EX-101.PRE ocul-20250611_pre.xml EX-101.PRE 10680
24 EXTRACTED XBRL INSTANCE DOCUMENT ocul-20250611xpre14a_htm.xml XML 447923
Mailing Address 15 CROSBY DRIVE BEDFORD MA 01730
Business Address 15 CROSBY DRIVE BEDFORD MA 01730 781-357-4000
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36554 | Film No.: 25850643
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)